Chamber-Made: Mural Endocarditis

Rutlen, Christine; Vallurupalli, Srikanth

doi:10.1016/j.amjmed.2018.03.027

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cases of MIE have been described in Candida and Aspergillus endocarditis [2,[7][8][9][10][11][12] as well as in infective endocarditis (IE) caused by other microorganisms more characteristic of valvular endocarditis (VIE) such as Staphylococcus aureus and Streptococcus. Others have described MIE in intravenous drug users or associated with catheter use [1,5,7,[13][14][15][16][17].…”

Section: Introductionmentioning

confidence: 99%

Mural Endocarditis: The GAMES Registry Series and Review of the Literature

et al. 2021

View full text Add to dashboard Cite

Introduction: Mural infective endocarditis (MIE) is a rare type of endovascular infection. We present a comprehensive series of patients with mural endocarditis. Methods: Patients with infectious endocarditis (IE) from 35 Spanish hospitals were prospectively included in the GAMES registry between 2008 and 2017. MIEs were compared to non-MIEs. We also performed a literature search for cases of MIE published between 1979 and 2019 and compared them to the GAMEs series. Results: Twenty-seven MIEs out of 3676 IEs were included. When compared to valvular IE (VIE) or device-associated IE (DIE), patients with MIE were younger (median age 59 years, p \ 0.01). Transplantation (18.5% versus 1.6% VIE and 2% DIE, p \ 0.01), hemodialysis (18.5% versus 4.3% VIE and 4.4% DIE, p = 0.006),

show abstract